Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FISHBANE, S")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1
Export

Selection :

  • and

THE FOUNDING OF KOLLEL AMERICA TIFERETH YERUSHALAYIMFISHBANE S.AMERICAN JEWISH HISTORICAL QUARTERLY. 1974, Vol 64, Num 2, pp 120-136Article

Intravenous infusion of total dose iron in peritoneal dialysis patients : A critical appraisalFISHBANE, S.American journal of kidney diseases. 1998, Vol 32, Num 6, pp 1086-1090, issn 0272-6386Article

Hyporesponsiveness to recombinant human erythropoietin in dialysis patientsFISHBANE, S.Dialysis & transplantation. 2000, Vol 29, Num 9, pp 545-548, issn 0090-2934, 581 [3 p.]Article

Exercise-induced renal and electrolyte changes: minimizing the risksFISHBANE, S.Physician and sportsmedicine. 1995, Vol 23, Num 8, pp 39-46, issn 0091-3847, 6 p.Article

Refractory anemia in a patient with allergy to intravenous iron drugsFISHBANE, S.Kidney international. 2006, Vol 69, Num 10, pp 1910-1913, issn 0085-2538, 4 p.Article

«In any case there are no sinful thoughts» ― the role and status of women in Jewish law as expressed in the Arukh HashulhanFISHBANE, S.Judaism. 1993, Vol 42, Num 168, pp 492-503, issn 0022-5762Article

Iron management in end-stage renal diseaseFISHBANE, S; MAESAKA, J. K.American journal of kidney diseases. 1997, Vol 29, Num 3, pp 319-333, issn 0272-6386Article

The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patientsFISHBANE, S; LYNN, R. I.Clinical nephrology. 1995, Vol 44, Num 4, pp 238-240, issn 0301-0430Article

The new FDA label for erythropoietin treatment : How does it affect hemoglobin target?FISHBANE, S; NISSENSON, A. R.Kidney international. 2007, Vol 72, Num 7, pp 806-813, issn 0085-2538, 8 p.Article

The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patientsFISHBANE, S; LYNN, R. I.American journal of kidney diseases. 1995, Vol 25, Num 3, pp 426-432, issn 0272-6386Article

Regulation of renal urate excretion : A critical reviewMAESAKA, J. K; FISHBANE, S.American journal of kidney diseases. 1998, Vol 32, Num 6, pp 917-933, issn 0272-6386Article

Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsRUGGIAN, J. C; MAESAKA, J. K; FISHBANE, S et al.American journal of kidney diseases. 1996, Vol 28, Num 3, pp 409-414, issn 0272-6386Article

Is there material hazard to treatment with intravenous iron?FISHBANE, S; MAESAKA, J. K; MITTAL, S. K et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 11, pp 2595-2598, issn 0931-0509Conference Paper

Cerebral salt-wasting syndrome : Does it exist?MAESAKA, J. K; GUPTA, S; FISHBANE, S et al.Nephron. 1999, Vol 82, Num 2, pp 100-109, issn 0028-2766Article

Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patientsDEVITA, M. V; FRUMKIN, D; MITTAL, S et al.Clinical nephrology. 2003, Vol 60, Num 5, pp 335-340, issn 0301-0430, 6 p.Article

Partial characterization of apoptotic factor in Alzheimer plasmaMAESAKA, J. K; PALAIA, T; CHOWDHURY, S. A et al.American journal of physiology. Renal physiology. 1999, Vol 45, Num 4, pp F521-F527, issn 1931-857XArticle

Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patientsFISHBANE, S; GALGANO, C; LANGLEY, R. C et al.Kidney international. 1997, Vol 52, Num 1, pp 217-222, issn 0085-2538Conference Paper

Hypervitaminosis A in two hemodialysis patientsFISHBANE, S; FREI, G. L; FINGER, M et al.American journal of kidney diseases. 1995, Vol 25, Num 2, pp 346-349, issn 0272-6386Article

Renal salt wasting without cerebral disease : Diagnostic value of urate determinations in hyponatremiaMAESAKA, J. K; MIYAWAKI, N; PALAIA, T et al.Kidney international. 2007, Vol 71, Num 8, pp 822-826, issn 0085-2538, 5 p.Article

Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patientsFISHBANE, S; YOUN, S; FLASTER, E et al.American journal of kidney diseases. 1996, Vol 27, Num 5, pp 668-672, issn 0272-6386Article

Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremiaFISHBANE, S; BUCALA, R; PEREIRA, B. J. G et al.Kidney international. 1997, Vol 52, Num 6, pp 1645-1650, issn 0085-2538Article

Paraneoplastic syndromes of the kidneyMAESAKA, J. K; MITTAL, S. K; FISHBANE, S et al.Seminars in oncology. 1997, Vol 24, Num 3, pp 373-381, issn 0093-7754Article

The safety of intravenous iron dextran in hemodialysis patientsFISHBANE, S; UNGUREANU, V.-D; MAESAKA, J. K et al.American journal of kidney diseases. 1996, Vol 28, Num 4, pp 529-534, issn 0272-6386Article

  • Page / 1